UBA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.881220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.440000E-01
Normal-vs-Stage2
1.324830E-01
Normal-vs-Stage3
6.438400E-02
Normal-vs-Stage4
5.599600E-01
Stage1-vs-Stage2
8.311800E-02
Stage1-vs-Stage3
5.490400E-02
Stage1-vs-Stage4
5.943800E-01
Stage2-vs-Stage3
1.702410E-01
Stage2-vs-Stage4
5.525000E-01
Stage3-vs-Stage4
2.436400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.936360E-01
Normal-vs-AfricanAmerican
6.987000E-01
Normal-vs-Asian
7.688200E-02
Caucasian-vs-AfricanAmerican
3.026000E-01
Caucasian-vs-Asian
1.876760E-01
AfricanAmerican-vs-Asian
1.291050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.781980E-01
Normal-vs-Female
2.218600E-01
Male-vs-Female
7.828000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.783000E-01
Normal-vs-Age(41-60Yrs)
2.547000E-01
Normal-vs-Age(61-80Yrs)
1.768000E-01
Normal-vs-Age(81-100Yrs)
2.547200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.724000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.365200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.559800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.412000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.428000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.460000E-02
Normal-vs-Daily Drinker
1.486110E-02
Normal-vs-Weekly Drinker
2.210400E-01
Normal-vs-Occasional Drinker
5.731800E-01
Normal-vs-Social Drinker
4.733600E-01
Non Drinker-vs-Daily Drinker
1.599020E-01
Non Drinker-vs-Weekly Drinker
8.704200E-01
Non Drinker-vs-Occasional Drinker
2.150200E-01
Non Drinker-vs-Social Drinker
1.917390E-01
Daily Drinker-vs-Weekly Drinker
2.200000E-01
Daily Drinker-vs-Occasional Drinker
3.644000E-02
Daily Drinker-vs-Social Drinker
2.189500E-02
Weekly Drinker-vs-Occasional Drinker
3.706000E-01
Weekly Drinker-vs-Social Drinker
3.940400E-01
Occasional Drinker-vs-Social Drinker
9.187600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.296300E-02
Normal-vs-Grade 2
1.180000E-02
Normal-vs-Grade 3
7.375600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.241600E-01
Grade 1-vs-Grade 3
4.867800E-01
Grade 1-vs-Grade 4
8.296300E-02
Grade 2-vs-Grade 3
3.228800E-01
Grade 2-vs-Grade 4
1.180000E-02
Grade 3-vs-Grade 4
7.375600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.870300E-02
Normal-vs-NonDiabetic
1.558370E-01
Diabetic-vs-NonDiabetic
3.198000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.720300E-02
Normal-vs-NoPancreatitis
1.334440E-01
Pancreatitis-vs-NoPancreatitis
7.668400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.478600E-01
Normal-vs-N1
1.313450E-01
N0-vs-N1
5.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.409400E-01
Normal-vs-TP53-NonMutant
7.698800E-01
TP53-Mutant-vs-TP53-NonMutant
3.694100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
